It acts as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, which helps regulate blood sugar levels
Mito-Morphosis: Mitochondrial fusion, fission, and cristae remodeling as key mediators of cellular function
It says conjugated linoleic acid has minimal direct interaction with GLP-1 therapy and possible mild gastrointestinal upset, but calls its efficacy unproven
"GLP-1 and GIP inhibitors are amazing medications at doing what they were developed for -- managing blood sugar in people with type 2 diabetes and weight loss in obesity," said study investigator Kelly Allison, PhD, a professor of Psychiatry and Director of the Center for Weight and Eating Disorders
Frontiers in Endocrinology, 12, 741764